Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice.
about
Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer diseaseThe role of tau in neurodegenerative diseases and its potential as a therapeutic targetPrion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic targetTau and tauopathiesTau physiology and pathomechanisms in frontotemporal lobar degenerationTau Biology and Tau-Directed Therapies for Alzheimer's DiseaseEffects of optineurin siRNA on apoptotic genes and apoptosis in RGC-5 cellsTau reduction prevents Abeta-induced defects in axonal transport.Increased dendritic spine density and tau expression are associated with individual differences in steroidal regulation of male sexual behavior.Neurofilaments form a highly stable stationary cytoskeleton after reaching a critical level in axons.Anchored FRET sensors detect local caspase activation prior to neuronal degenerationAmyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.Amyloid-β oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neuronsSingle-molecule tracking of tau reveals fast kiss-and-hop interaction with microtubules in living neuronsIn vivo axonal transport deficits in a mouse model of fronto-temporal dementia.The myosin Va head domain binds to the neurofilament-L rod and modulates endoplasmic reticulum (ER) content and distribution within axonsTau potentiates nerve growth factor-induced mitogen-activated protein kinase signaling and neurite initiation without a requirement for microtubule binding.Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction.Motor and cognitive deficits in aged tau knockout mice in two background strains.GSK3β is involved in the relief of mitochondria pausing in a Tau-dependent mannerIncreased Human Wildtype Tau Attenuates Axonal Transport Deficits Caused by Loss of APP in Mouse ModelsReduced axonal transport and increased excitotoxic retinal ganglion cell degeneration in mice transgenic for human mutant P301S tau.Loss of the m-AAA protease subunit AFG₃L₂ causes mitochondrial transport defects and tau hyperphosphorylation.The C-terminal domains of NF-H and NF-M subunits maintain axonal neurofilament content by blocking turnover of the stationary neurofilament networkThe Ca2+ sensor protein swiprosin-1/EFhd2 is present in neurites and involved in kinesin-mediated transport in neurons.Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's diseaseTau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β.Dissociation of Axonal Neurofilament Content from Its Transport RateThe many faces of tauLessons from tau-deficient micePathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferasesTau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?Soluble forms of tau are toxic in Alzheimer's disease.Absence of Tau triggers age-dependent sciatic nerve morphofunctional deficits and motor impairmentPATHOLOGIES OF AXONAL TRANSPORT IN NEURODEGENERATIVE DISEASESNon-invasive, in vivo monitoring of neuronal transport impairment in a mouse model of tauopathy using MEMRITau pathology-mediated presynaptic dysfunctionDissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila modelPhosphorylated tau: toxic, protective, or none of the aboveTau aggregation and toxicity in tauopathic neurodegenerative diseases.
P2860
Q24657243-A7DCA7F6-AEF3-4BD8-A5DD-C576644B1B37Q27005032-3231C06A-A266-49A2-B359-C44B32F02234Q27021159-8983EE41-91E4-4F6F-B895-C3840FECECBBQ27027415-21D31019-5E87-45BD-8B6B-938D3A1E4017Q28070250-8199F7E8-25DE-4080-8E56-D631507AF0AEQ28071398-2E447D48-2FD6-489C-8CDF-366F3D34AD2BQ28574168-06C47AE7-F876-4F69-8806-28BED7DEEA83Q28585545-4421DB27-A025-4380-BCF4-5F1C72E0E47FQ30418177-AB48C27A-B5E6-43E6-BC97-C5F9D94C80E0Q30492186-9D55B402-0A17-4D3D-A0E1-10E348BEC4B1Q30501542-0E3EC3CC-C1B7-4F9F-8D71-B485FB77E15BQ30513293-08810890-948F-46C2-8B12-3B842A1EFF1EQ30542949-59FF71A6-CABF-400A-9D84-74DCECC95B13Q30597670-375CB9A3-4D77-4406-80CD-9B88213F469EQ30831646-0B4FC96D-F8B8-406B-A838-917B9148D172Q33832083-ABD4381C-E1B8-40E6-A2CE-5CDDF06101C0Q33911246-134DA0DC-BD69-4009-9808-5610C8E8CB53Q34073334-002C1A50-6908-473B-ADCA-60AFAE9E8FB9Q34077327-78763202-57E1-4A75-BDC2-6B3215FBB937Q34081720-5BC4F377-B267-446D-AFB0-B95CB3B261E5Q34082420-AF7E01E6-A6D6-4AE1-AEA3-3B2A10F82E0EQ34230291-DB5F0079-D2D0-45BB-9A98-07ADB65DE9D5Q34323864-B5FB784C-57F5-4C56-8A75-FF9D2216A1CEQ34427014-AFD06D25-806C-4345-BEB7-09F37198D64DQ35227303-1845AAB2-C4A7-4727-BAAD-26E0A762A6A4Q35418159-A83BAD54-AA67-4ABE-A472-56113AC857D3Q35594575-9568B37D-73BD-4B2D-A5D6-FF5CCF199A0FQ35711791-8C826F8F-B9DD-4D46-BE86-5DD328C00CE0Q35870359-88B61F93-7309-4C4E-AFEE-33DDFBF648E7Q36031983-D014F88F-03E8-48B1-934E-DC0BC400BCABQ36082071-E573F8B3-0C12-4D57-A4FF-1A9B97B51623Q36241505-2165A1B1-BED2-4C31-9DE9-514E889260A2Q36286360-A35431B8-1715-4A26-8AF6-CD7475D4D5ADQ36665475-3971A2C0-22F0-40F6-861A-F8CBC6024A9EQ36907760-67A25407-A306-4A8C-B652-1B41518D85E1Q36915739-D1CD8227-0CCA-4971-BD37-F1BADF758E76Q36951523-80E7CA2F-E3AD-4FFD-A7FF-37F66C062DD6Q37102130-D6EDDBE7-6F00-40EF-B7AF-4B4574463603Q37238262-DCFDD577-31E0-4E0B-B5E4-BA3458E7C8BBQ37238281-5451D4D7-0AC9-4E17-B04E-0FAF34C69CF0
P2860
Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice.
@ast
Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice.
@en
type
label
Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice.
@ast
Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice.
@en
prefLabel
Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice.
@ast
Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice.
@en
P2093
P2860
P1476
Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice.
@en
P2093
Aidong Yuan
Asok Kumar
Corrinne Peterhoff
Karen Duff
Ralph A Nixon
P2860
P304
P356
10.1523/JNEUROSCI.5242-07.2008
P407
P577
2008-02-01T00:00:00Z